October 2022

Taiwan men’s doubles shuttlers finish second at BWF French Open

Taiwan’s Yang Po-han (楊博涵) and Lu Ching-yao (盧敬堯) settled for the runners-up spot at the BWF French Open after losing to India’s Chirag Shetty and Satwiksairaj Rankireddy in the men’s doubles final on Sunday. The world No. 25 Taiwanese pair were defeated by the world No. 8 Indian pairing in

>

Weather bureau raises extreme torrential rain alert for part of Yilan

An extreme torrential rain warning has been issued for mountainous areas in Yilan County, northeastern Taiwan, by the Central Weather Bureau (CWB) on Monday morning, indicating those places could receive over 500 millimeters of rain within the next 24 hours. As of 10:30 a.m. Monday, Ximao Shan (Mt. Ximao) on

>

Taiwan shares close up 1.26%

Taiwan shares closed up 161.33 points, or 1.26 percent, at 12,949.75 on Monday on turnover of NT$167.7 billion (US$5.19 billion).     Source: Focus Taiwan News Channel

>

COVID outbreak at Zhengzhou plant in China under control: Hon Hai

In response to speculation that operations at its Chinese plant in Zhengzhou had been disrupted by COVID-19, electronics giant Hon Hai Precision Industry Co. said Sunday that the situation there was under control with the cooperation of local authorities. In a statement, Hon Hai, known as Foxconn globally, underlined that

>

Taiwan reports 22,634 new COVID-19 cases, 59 deaths

Taiwan reported 22,634 new COVID-19 infections Monday, including 41 imported cases, and 59 deaths from the disease, according to the Central Epidemic Command Center (CECC). The deaths reported Monday involved individuals who ranged in age from their 40s to their 90s. All but four had underlying health issues, while 31

>

Conagen’s fermentation platform expands on promising novel forms of vitamin K2

Bedford, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) — Biotech innovator, Conagen announced the development of its fermentation-derived vitamin K2 – a high-purity all-trans menaquinone-7 (MK-7).  This is the first molecule from a proprietary platform for producing novel, pure, long-chain menaquinone forms of the vitamin. The platform enables low-cost manufacturing and

>